Guizhounli Pharmaceutical Co (SHSE:603439) E10: ¥0.46 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603439 Guizhou Sanli Pharmaceutical Co Ltd SHSE:603439
90 GF Score
Price ¥11.41
GF Value ¥14.70
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Guizhounli Pharmaceutical Co E10?

Guizhounli Pharmaceutical Co SHSE:603439 -1.98% 90 E10 is ¥0.46 as of Mar. 2026. GuruFocus rates SHSE:603439 with a GF Score™ of 90/100 and a GF Value™ of ¥14.70 (Modestly Undervalued). The stock has 10 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Guizhounli Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was ¥0.110. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.46 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-16), Guizhounli Pharmaceutical Co's current stock price is ¥11.41. Guizhounli Pharmaceutical Co's E10 for the quarter that ended in Mar. 2026 was ¥0.46. Guizhounli Pharmaceutical Co's Shiller PE Ratio of today is 24.80.

During the past 13 years, the highest Shiller PE Ratio of Guizhounli Pharmaceutical Co was 36.96. The lowest was 23.74. And the median was 26.03.


Guizhounli Pharmaceutical Co  (SHSE:603439) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Guizhounli Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=11.41/0.46
=24.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Guizhounli Pharmaceutical Co was 36.96. The lowest was 23.74. And the median was 26.03.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Guizhounli Pharmaceutical Co E10 Related Terms


Guizhounli Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Guizhounli Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guizhounli Pharmaceutical Co E10 Chart

Guizhounli Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.46

Guizhounli Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.46 0.46

SHSE:603439 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Guizhounli Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guizhounli Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guizhounli Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Guizhounli Pharmaceutical Co's Shiller PE Ratio falls into.


SHSE:603439
90GF Score
Guizhou Sanli Pharmaceutical Co Ltd SHSE:603439
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guizhounli Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Guizhounli Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.11/116.3033*116.3033
=0.110

Current CPI (Mar. 2026) = 116.3033.

Guizhounli Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201412 0.000 99.000 0.000
201506 0.000 99.500 0.000
201512 0.000 100.600 0.000
201606 0.000 101.400 0.000
201612 0.000 102.600 0.000
201703 0.027 103.200 0.030
201706 0.043 103.100 0.049
201712 0.000 104.500 0.000
201803 0.076 105.300 0.084
201806 0.080 104.900 0.089
201812 0.000 106.500 0.000
201903 0.059 107.700 0.064
201906 0.091 107.700 0.098
201909 0.260 109.800 0.275
201912 0.100 111.200 0.105
202003 0.070 112.300 0.072
202006 0.050 110.400 0.053
202009 0.120 111.700 0.125
202012 0.120 111.500 0.125
202103 0.060 112.662 0.062
202106 0.110 111.769 0.114
202109 0.100 112.215 0.104
202112 0.100 113.108 0.103
202203 0.060 114.335 0.061
202206 0.100 114.558 0.102
202209 0.090 115.339 0.091
202212 0.240 115.116 0.242
202303 0.130 115.116 0.131
202306 0.120 114.558 0.122
202309 0.140 115.339 0.141
202312 0.320 114.781 0.324
202403 0.140 115.227 0.141
202406 0.150 114.781 0.152
202409 0.180 115.785 0.181
202412 0.200 114.893 0.202
202503 0.100 115.116 0.101
202506 0.100 114.907 0.101
202509 0.000 115.471 0.000
202512 -0.090 115.832 -0.090
202603 0.110 116.303 0.110

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ¥0.46 mean?
Guizhounli Pharmaceutical Co (SHSE:603439) has a E10 of ¥0.46 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Guizhounli Pharmaceutical Co and its competitors.
Is Guizhounli Pharmaceutical Co's E10 too high?
Guizhounli Pharmaceutical Co's current E10 is ¥0.46. Overall, Guizhounli Pharmaceutical Co has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Guizhounli Pharmaceutical Co's E10 compare to ZTS and UTHR?
Guizhounli Pharmaceutical Co's E10 of ¥0.46 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Guizhounli Pharmaceutical Co and its competitors. Guizhounli Pharmaceutical Co's current E10 is ¥0.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guizhounli Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Guizhounli Pharmaceutical Co (SHSE:603439) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥14.70, compared to a current price of ¥11.41 — trading 22.4% below its estimated fair value. The current E10 is ¥0.46. Guizhounli Pharmaceutical Co's overall GF Score™ is 90/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Guizhounli Pharmaceutical Co (SHSE:603439), the current E10 is ¥0.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guizhounli Pharmaceutical Co (SHSE:603439) Overvalued in 2026?

Based on GuruFocus' analysis, Guizhounli Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥11.41 is trading 22.4% below its estimated GF Value™ of ¥14.70. GuruFocus considers Guizhounli Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:603439:

  • E10: ¥0.46
  • GF Value™: ¥14.70 vs. price of ¥11.41 (22.4% below fair value)
  • GF Score™: 90/100 with 10 warning signs

No single metric tells the full story. See the SHSE:603439 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guizhounli Pharmaceutical Co Business Description

Address Xiayun Industrial Park, Pingba District, Guizhou Province, Anshun, CHN, 561000
Guizhou Sanli Pharmaceutical Co Ltd is engaged in Chinese pharmaceutical research, development, production and marketing. The company produces and sells soft capsules, hard capsules, sprays (including Chinese medicine extraction) and provides Chinese medicine science and technology consulting services. Its products include Pediatric medication; Respiratory system medication; Cardiovascular and cerebrovascular drugs; Digestive medicine; Trauma injury medication; Rehabilitation medicine; and Ophthalmic medicine.
90GF Score

Get the complete analysis for SHSE:603439

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.41
Price
¥14.70
GF Value